Continuous Remote Monitoring in Moderate and Severe COVID-19 Patients

被引:1
|
作者
Rajanna, Avinash H. [1 ,2 ]
Bellary, Vaibhav S. [1 ,2 ]
Puranic, Sohani Kashi [1 ,2 ]
Nayana, C. [1 ,2 ]
Nagaraj, Jatin Raaghava [1 ,2 ]
Eshanye, D. A. [1 ,2 ]
Preethi, K. [1 ,2 ]
机构
[1] Employees State Insurance Corp & Med Coll ESIC MC, Gen Med, Bangalore, India
[2] Post Grad Inst Med Sci & Res PGIMSR, Model Hosp, Bangalore, India
关键词
early warning score; clinical deterioration; continuous monitoring; remote monitoring; covid-19; contactless; EARLY WARNING SCORE; DETERIORATION; VALIDATION;
D O I
10.7759/cureus.44528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background COVID-19 steadily built up the pressure on healthcare systems worldwide, creating the need for novel methods to alleviate the burden. Continuous remote monitoring of vital parameters reduces morbidity and mortality in hospitals by providing real-time disease data that can be analyzed through web portals. It enables healthcare workers to identify which patients require prompt administration of healthcare. Patients remain under the purview of their doctors and can be notified early if there are any deteriorations in the parameters being monitored. Aims To evaluate the use of remote monitoring in moderate and severe COVID-19 patients and to correlate the Dozee Early Warning Score (DEWS) with severity and outcome in moderate and severe COVID-19 patients. Materials and methods We conducted a prospective study on adult (>18 years old) moderate and severe COVID-19 patients during the second wave of COVID-19. The vitals of the subjects were continuously monitored using Dozee, a contactless remote patient monitoring system enabled with DEWS that reflects the overall patient condition based on respiratory rate (RR), heart rate (HR), and oxygen saturation (SpO(2)). We assessed the correlation of DEWS with patients' clinical outcomes: deteriorated or recovered. Results Thirty-nine COVID-19 patients were recruited for the study, of whom 29 were discharged after recovery and 10 deteriorated and died. Respiratory rate trend, respiratory rate DEWS, SpO(2 )DEWS, and total DEWS showed a significant reduction in recovered patients, while the same parameters showed a significant increase followed by consistently high scores in patients who deteriorated and died due to the disease. Total DEWS was proportional to the risk of mortality in a patient. Conclusion We concluded that continuous vitals monitoring and the resulting DEWS in moderate and severe COVID-19 patients were indicators of their improvement or deterioration. DEWS uses continuous remote monitoring of routinely collected vitals (HR, RR, and SpO(2)) to serve as a predictor of patient outcome.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] SPIROMETRY IN COVID-19 PNEUMONIA PATIENTS ON CONTINUOUS REMOTE PATIENT MONITORING
    Loudermilk, Kevin
    Morris, Michael
    Kinshella, Theresa
    Yourk, Daniel
    Smith, Caitlin
    Hipp, Sean
    Walter, Robert
    [J]. CHEST, 2021, 160 (04) : 571A - 572A
  • [2] Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients
    Sobel, Jonathan A.
    Levy, Jeremy
    Almog, Ronit
    Reiner-Benaim, Anat
    Miller, Asaf
    Eytan, Danny
    Behar, Joachim A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [3] Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients
    Jonathan A. Sobel
    Jeremy Levy
    Ronit Almog
    Anat Reiner-Benaim
    Asaf Miller
    Danny Eytan
    Joachim A. Behar
    [J]. Scientific Reports, 13 (1)
  • [4] Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes
    Ushigome, Emi
    Yamazaki, Masahiro
    Hamaguchi, Masahide
    Ito, Takamasa
    Matsubara, Shin
    Tsuchido, Yasuhiro
    Kasamatsu, Yu
    Nakanishi, Masaki
    Fujita, Naohisa
    Fukui, Michiaki
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 78 - 80
  • [5] Residual symptoms in moderate to severe COVID-19 patients
    Elfidha, Sabrine
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Marzouki, Safa
    Kaabi, Line
    Jebeli, Rihab
    Kharrat, Mohamed Ali
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] The effect of Fingolimod on patients with moderate to severe COVID-19
    Teymouri, Soheil
    Kaleybar, Siamak Pourbayram
    Hejazian, Seyyed Sina
    Hejazian, Seyyedeh Mina
    Ansarin, Khalil
    Ardalan, Mohammadreza
    Vahed, Sepideh Zununi
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [7] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [8] Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC
    Annunziata, Anna
    Coppola, Antonietta
    Carannante, Novella
    Simioli, Francesca
    Lanza, Maurizia
    Di Micco, Pierpaolo
    Fiorentino, Giuseppe
    [J]. PATHOGENS, 2021, 10 (04):
  • [9] Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients
    Eisenkraft, Arik
    Maor, Yasmin
    Constantini, Keren
    Goldstein, Nir
    Nachman, Dean
    Levy, Ran
    Halberthal, Michael
    Horowitz, Netanel A.
    Golan, Ron
    Rosenberg, Elli
    Lavon, Eitan
    Cohen, Ornit
    Shapira, Guy
    Shomron, Noam
    Ishay, Arik Ben
    Sand, Efrat
    Merin, Roei
    Fons, Meir
    Littman, Romi
    Gepner, Yftach
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [10] CONTINUOUS REMOTE PATIENT MONITORING SHOWS EARLY CARDIOVASCULAR CHANGES IN COVID-19 PATIENTS
    Eisenkraft, Arik
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E172 - E172